Slide Insurance (SLDE) risk chief exercises options and sells 20,000 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Slide Insurance Holdings, Inc. Chief Risk Officer Matthew Paul Larson exercised stock options and sold the resulting shares in open-market transactions. He exercised a total of 20,000 options at an exercise price of $0.79 per share and sold 20,000 common shares in two trades at prices around $19 per share.
The sales, totaling 20,000 shares, were completed pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2025, meaning they were pre-scheduled. Following these transactions, he directly holds no common stock and retains 1,250 stock options that are fully vested and exercisable, expiring on February 21, 2032.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 20,000 shares ($384,388)
Net Sell
6 txns
Insider
LARSON MATTHEW PAUL
Role
Chief Risk Officer
Sold
20,000 shs ($384K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 11,250 | $0.00 | -- |
| Exercise | Common Stock | 11,250 | $0.79 | $9K |
| Sale | Common Stock | 11,250 | $19.39 | $218K |
| Exercise | Stock Option (Right to Buy) | 8,750 | $0.00 | -- |
| Exercise | Common Stock | 8,750 | $0.79 | $7K |
| Sale | Common Stock | 8,750 | $19.00 | $166K |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,250 shares (Direct, null);
Common Stock — 11,250 shares (Direct, null)
Footnotes (1)
- Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.97 to $19.91 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. These stock options are fully vested and exercisable.
Key Figures
Shares sold: 20,000 shares
Sale price 4/16: $19.00 per share
Sale price 4/20: $19.39 per share
+5 more
8 metrics
Shares sold
20,000 shares
Total common stock sold in open-market transactions
Sale price 4/16
$19.00 per share
Price for 8,750 common shares sold on April 16, 2026
Sale price 4/20
$19.39 per share
Price for 11,250 common shares sold on April 20, 2026
Price range
$18.97–$19.91 per share
Disclosed range of prices for sold shares
Option exercise price
$0.79 per share
Exercise price of stock options converted into common stock
Options exercised
20,000 options
Total stock options exercised into common shares
Options remaining
1,250 options
Stock options still held after transactions, fully vested
Option expiration
February 21, 2032
Expiration date of remaining stock options
Key Terms
Rule 10b5-1 trading plan, Stock Option (Right to Buy), weighted average price, fully vested and exercisable, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option (Right to Buy) financial
""security_title": "Stock Option (Right to Buy)""
weighted average price financial
"Represents the weighted average price of the shares sold."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
fully vested and exercisable financial
"These stock options are fully vested and exercisable."
open-market sale financial
""transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
What insider transaction did SLDE’s Chief Risk Officer report on this Form 4?
SLDE’s Chief Risk Officer, Matthew Paul Larson, reported exercising 20,000 stock options and selling 20,000 common shares. The trades occurred in two batches on April 16 and April 20, converting option-based compensation into cash through open-market sales.
What stock options did the SLDE insider exercise in this filing?
He exercised 20,000 stock options with a conversion or exercise price of $0.79 per share, in two tranches of 8,750 and 11,250 options. The filing notes these options are fully vested and exercisable, reflecting previously earned equity compensation.
Was the Slide Insurance (SLDE) insider sale under a Rule 10b5-1 trading plan?
Yes. The filing states the options were exercised and shares sold pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2025. Such plans pre-schedule trades, indicating these sales were arranged in advance rather than timed opportunistically.
What are the SLDE insider’s holdings after these transactions?
After completing the transactions, Matthew Paul Larson holds no Slide Insurance common stock directly. He retains 1,250 stock options with a $0.79 exercise price that remain outstanding and fully vested, scheduled to expire on February 21, 2032.